The Emerging FGF21 Axis in Thyroid Eye Disease: Metabolic–Immune Crosstalk and Therapeutic Perspectives. CDF [Internet]. 2024 Nov. 20 [cited 2026 Oct. 24];53(03):8489-97. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/4320